NABI BIOPHARMACEUTICALS
--------------------------------------------------------------------------------
                                                                    EXHIBIT 23.1


                             CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



We consent to the incorporation by reference in the Registration Statement (Form
S-3 No. 333-42188) and in the related Prospectus of Nabi Biopharmaceuticals and
the Registration Statements (Forms S-8 No. 333-38868, No. 333-38866 and No.
333-38864) pertaining to the Nabi Savings and Retirement Plan, Nabi-Rockville
Savings and Retirement Plan, 2000 Equity Incentive Plan and 2000 Employee Stock
Purchase Plan of our report dated February 4, 2003, with respect to the
consolidated financial statements and schedule of Nabi Biopharmaceuticals
included in this Annual Report (Form 10-K) for the year ended December 28, 2002.




                                                           /s/ Ernst & Young LLP

February 27, 2003